NL7310392A - - Google Patents

Info

Publication number
NL7310392A
NL7310392A NL7310392A NL7310392A NL7310392A NL 7310392 A NL7310392 A NL 7310392A NL 7310392 A NL7310392 A NL 7310392A NL 7310392 A NL7310392 A NL 7310392A NL 7310392 A NL7310392 A NL 7310392A
Authority
NL
Netherlands
Application number
NL7310392A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7310392A publication Critical patent/NL7310392A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7310392A 1972-07-31 1973-07-26 NL7310392A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00276794A US3819628A (en) 1972-07-31 1972-07-31 2-phenyl-4-substituted amino-quinazolines and nitrates thereof

Publications (1)

Publication Number Publication Date
NL7310392A true NL7310392A (cg-RX-API-DMAC7.html) 1974-02-04

Family

ID=23058095

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7310392A NL7310392A (cg-RX-API-DMAC7.html) 1972-07-31 1973-07-26

Country Status (6)

Country Link
US (1) US3819628A (cg-RX-API-DMAC7.html)
JP (1) JPS4945083A (cg-RX-API-DMAC7.html)
BE (1) BE802996R (cg-RX-API-DMAC7.html)
DE (1) DE2338669A1 (cg-RX-API-DMAC7.html)
FR (1) FR2194437A2 (cg-RX-API-DMAC7.html)
NL (1) NL7310392A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530894A1 (de) * 1974-07-25 1976-02-05 Pfizer Chinanzolinderivate

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5122605B1 (cg-RX-API-DMAC7.html) * 1970-07-20 1976-07-10
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives
US4306065A (en) * 1979-12-19 1981-12-15 A. H. Robins Company, Incorporated 2-Aryl-4-substituted quinazolines
US4377582A (en) * 1979-12-19 1983-03-22 A. H. Robins Company, Inc. 2-Phenyl-4-[cis-2,5-dimethyl-4-(2-pyridinyl)-1-piperazinyl]quinazoline
US4639454A (en) * 1985-01-17 1987-01-27 E. I. Du Pont De Nemours And Company Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
DE19756388A1 (de) 1997-12-18 1999-06-24 Hoechst Marion Roussel De Gmbh Substituierte 2-Aryl-4-amino-chinazoline
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7718658B2 (en) * 2004-09-02 2010-05-18 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) * 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
EP1828150B1 (en) * 2004-12-17 2012-03-14 Vertex Pharmaceuticals Incorporated Processes for producing 4-aminoquinazolines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530894A1 (de) * 1974-07-25 1976-02-05 Pfizer Chinanzolinderivate

Also Published As

Publication number Publication date
BE802996R (fr) 1974-01-30
DE2338669A1 (de) 1974-02-21
US3819628A (en) 1974-06-25
JPS4945083A (cg-RX-API-DMAC7.html) 1974-04-27
FR2194437A2 (cg-RX-API-DMAC7.html) 1974-03-01

Similar Documents

Publication Publication Date Title
FR2180090A1 (cg-RX-API-DMAC7.html)
FR2194437A2 (cg-RX-API-DMAC7.html)
JPS48100812U (cg-RX-API-DMAC7.html)
JPS4890984A (cg-RX-API-DMAC7.html)
JPS5226314B2 (cg-RX-API-DMAC7.html)
JPS48109801U (cg-RX-API-DMAC7.html)
CS161013B1 (cg-RX-API-DMAC7.html)
JPS4996387U (cg-RX-API-DMAC7.html)
JPS4929098A (cg-RX-API-DMAC7.html)
JPS4896072A (cg-RX-API-DMAC7.html)
CH562332A5 (cg-RX-API-DMAC7.html)
CH560331A5 (cg-RX-API-DMAC7.html)
DD109238A5 (cg-RX-API-DMAC7.html)
CH567359A5 (cg-RX-API-DMAC7.html)
CH566897A5 (cg-RX-API-DMAC7.html)
CH565891A (cg-RX-API-DMAC7.html)
CH564490A5 (cg-RX-API-DMAC7.html)
CH564259A5 (cg-RX-API-DMAC7.html)
CH563044A5 (cg-RX-API-DMAC7.html)
BG18717A1 (cg-RX-API-DMAC7.html)
CH562891A5 (cg-RX-API-DMAC7.html)
CH562883A (cg-RX-API-DMAC7.html)
DD100184A1 (cg-RX-API-DMAC7.html)
CH561793A5 (cg-RX-API-DMAC7.html)
CH561764A5 (cg-RX-API-DMAC7.html)